MAP4

• Description :

  MAP4 is a selective group III mGluR antagonist in some electrophysiological systems[1].

• UNSPSC :

  12352211

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  MGluR

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/map4.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC([C@@](C)(N)CCP(O)(O)=O)=O

• Molecular Formula :

  C5H12NO5P

• Molecular Weight :

  197.13

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Salt TE, Eaton SA. Distinct presynaptic metabotropic receptors for L-AP4 and CCG1 on GABAergic terminals: pharmacological evidence using novel alpha-methyl derivative mGluR antagonists, MAP4 and MCCG, in the rat thalamus in vivo. Neuroscience. 1995 Mar;65 (1) :5-13.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [157381-42-5]